John Douglas Haley
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
1989First federal award
$3.7MFederal grants as PI20 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
20 awards · $3.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 1, 1999 | NIH | SBIR/STTR Phase I PROTEIN TARGETS OF PHARMACOLOGIC HBF INDUCERS | $108K | — |
| Feb 1, 1997 | NIH | SBIR/STTR Phase II AMELIORATION OF ORAL MUCOSITIS IN ANIMAL MODELS | $238K | — |
| Feb 1, 1997 | NIH | SBIR/STTR Phase II AMELIORATION OF ORAL MUCOSITIS IN ANIMAL MODELS | $243K | — |
| Feb 1, 1997 | NIH | SBIR/STTR Phase I AMELIORATION OF ORAL MUCOSITIS IN ANIMAL MODELS | $97K | — |
| Sep 30, 1996 | NIH | NIH R01 INDUCTION OF HBF FOR SICKLE CELL AND B-THALASSEMIA | $300K | — |
| Sep 30, 1996 | NIH | NIH R01 INDUCTION OF HBF FOR SICKLE CELL AND B-THALASSEMIA | $300K | — |
| Sep 30, 1996 | NIH | NIH R01 INDUCTION OF HBF FOR SICKLE CELL AND B-THALASSEMIA | $300K | — |
| Sep 1, 1995 | NIH | SBIR/STTR Phase I THALASSEMIA AND B AND D GLOBIN GENE EXPRESSION | $100K | — |
| Feb 15, 1995 | NIH | SBIR/STTR Phase II FETAL HB GENE INDUCTION FOR SICKLE CELL & B-THALASSEMIA | $300K | — |
| Feb 15, 1995 | NIH | SBIR/STTR Phase II FETAL HB GENE INDUCTION FOR SICKLE CELL & B-THALASSEMIA | $310K | — |
| Sep 1, 1993 | NIH | SBIR/STTR Phase I FETAL HB GENE FOR SICKLE CELL AND BETA-THALASSEMIA | $50K | — |
| Aug 1, 1992 | NIH | SBIR/STTR Phase I DRUG SCREENING FOR ANTI-METASTATIC COMPOUNDS | $48K | — |
| Sep 1, 1991 | NIH | SBIR/STTR Phase I DEVELOPMENT OF GROWTH HORMONE RELEASING FACTOR AGONISTS | $45K | — |
| Sep 1, 1991 | NIH | SBIR/STTR Phase II TRANSCRIPTIONAL CONTROL OF THE EGF RECEPTOR GENE | $132K | — |
| Sep 1, 1991 | NIH | SBIR/STTR Phase II DEVELOPMENT OF GROWTH HORMONE RELEASING FACTOR AGONISTS | $250K | — |
| Sep 1, 1991 | NIH | SBIR/STTR Phase II TRANSCRIPTIONAL CONTROL OF THE EGF RECEPTOR GENE | $233K | — |
| Sep 1, 1991 | NIH | SBIR/STTR Phase II DEVELOPMENT OF GROWTH HORMONE RELEASING FACTOR AGONISTS | $250K | — |
| Sep 1, 1991 | NIH | SBIR/STTR Phase II TRANSCRIPTIONAL CONTROL OF THE EGF RECEPTOR GENE | $125K | — |
| Sep 1, 1991 | NIH | SBIR/STTR Phase I TRANSCRIPTIONAL CONTROL OF THE EGF RECEPTOR GENE | $49K | — |
| Apr 1, 1989 | NIH | SBIR/STTR Phase II TGF-BETA 3 PRODUCTION IN EUCARYOTES AND PROCARYOTES | $184K | — |
Peer ranks
Federal funding#105
Awards as PI#13
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.